Trimarchi Thomas (CIK 2030813) reported 18 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Sell BBIO (10,456 shares), Sell BBIO (3,195 shares), Sell BBIO (22,781 shares), Buy BBIO (59,041 shares), Sell BBIO (200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 10,456 | $677,707 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 3,195 | $210,712 |
| 2026-05-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 22,781 | $1.5M |
| 2026-03-20 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Buy | 59,041 | $0 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 200 | $15,076 |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 18,819 | $1.4M |
| 2026-02-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 13,400 | $1.0M |
| 2025-12-16 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 13,826 | $1.0M |
| 2025-11-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 21,317 | $1.4M |
| 2025-11-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 9,978 | $660,444 |
| 2025-11-18 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 6,956 | $464,939 |
| 2025-08-22 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 42,237 | $2.1M |
| 2025-08-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 21,317 | $1.1M |
| 2025-08-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 15,380 | $771,153 |
| 2025-08-19 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 1,973 | $100,505 |
| 2025-05-20 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Sell | 21,317 | $721,367 |
| 2025-03-21 | BridgeBio Pharma, Inc. (BBIO) | President and CFO | Buy | 109,100 | $0 |
| 2025-02-19 | BridgeBio Pharma, Inc. (BBIO) | President and COO | Sell | 13,782 | $480,992 |
Source: SEC Form 4 filings · as of 2026-05-19